Eris Lifesciences Ltd - 540596 - Announcement Under Regulation 30 (LODR) - Allotment Of Equity Shares Under ESOP Scheme
Allotment of Equity Shares under ESOP Scheme22-12-2023
22-12-2023
Eris Lifesciences Ltd - 540596 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund20-12-2023
Eris Lifesciences Ltd - 540596 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund20-12-2023
Eris Lifesciences Ltd - 540596 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Corporate Guarantee
Corporate Guarantee15-12-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meet Intimation06-12-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Analyst and Investor Call11-11-2023
Eris Lifesciences Ltd - 540596 - UPDATE ON ACQUISTION OF NEPHROLOGY AND DERMATOLOGY BUSINESSES OF BIOCON BIOLOGICS LIMITED
Closure of Acquisition10-11-2023